» Authors » Einat K Brenner

Einat K Brenner

Explore the profile of Einat K Brenner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 71
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez A, Edwards L, Thomas K, Weigand A, Bordyug M, Brenner E, et al.
Neuropsychology . 2025 Mar; 39(3):248-258. PMID: 40063372
Objective: Objectively defined subtle cognitive decline (Obj-SCD) is an emerging classification that may identify individuals at risk for future decline and progression to Alzheimer's disease prior to a diagnosis of...
2.
Edwards L, Thomas K, Weigand A, Edmonds E, Clark A, Brenner E, et al.
Cereb Circ Cogn Behav . 2024 Feb; 6:100206. PMID: 38328026
This study assessed whether the effect of vascular risk on cerebral blood flow (CBF) varies by gene dose of apolipoprotein (APOE) ε4 alleles. 144 older adults without dementia from the...
3.
Brenner E, Bangen K, Clark A, Delano-Wood L, Evangelista N, Edwards L, et al.
Front Aging Neurosci . 2024 Jan; 15:1267061. PMID: 38161592
Background: Decreasing white matter integrity in limbic pathways including the fornix and cingulum have been reported in Alzheimer's disease (AD), although underlying mechanisms and potential sex differences remain understudied. We...
4.
Membreno R, Thomas K, Calcetas A, Edwards L, Bordyug M, Showell M, et al.
Alzheimer Dis Assoc Disord . 2023 Nov; 37(4):303-309. PMID: 38015423
Introduction: White matter hyperintensities (WMHs) are magnetic resonance imaging markers of small vessel cerebrovascular disease that are associated with cognitive decline and clinical Alzheimer disease. Previous studies have often focused...
5.
Edwards L, Thomas K, Weigand A, Edmonds E, Clark A, Walker K, et al.
J Alzheimers Dis . 2023 Jun; 94(2):695-707. PMID: 37302031
Background: Alzheimer's disease (AD) and cerebrovascular disease are common, co-existing pathologies in older adults. Whether the effects of cerebrovascular disease and AD biomarkers on cognition are additive or synergistic remains...
6.
Brenner E, Weigand A, Edwards L, Thomas K, Edmonds E, Bondi M, et al.
J Alzheimers Dis . 2023 Mar; 93(1):141-149. PMID: 36970903
Background: Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays an important role in regulating synaptic activity and plasticity. Objective: Given that type-2 diabetes (T2DM) increases the risk of cognitive...
7.
Brenner E, Thomas K, Weigand A, Edwards L, Edmonds E, Bondi M, et al.
Neurobiol Aging . 2023 Mar; 125:83-89. PMID: 36868071
Higher cognitive reserve (CR) may offer protection from cognitive changes associated with reduced cerebral blood flow (CBF). We investigated CR as a moderator of the effect of CBF on cognition...
8.
Bangen K, Calcetas A, Thomas K, Wierenga C, Smith C, Bordyug M, et al.
J Int Neuropsychol Soc . 2023 Feb; 29(9):859-869. PMID: 36789631
Objectives: Physical activity (PA) may help maintain brain structure and function in aging. Since the intensity of PA needed to effect cognition and cerebrovascular health remains unknown, we examined associations...
9.
Holmqvist S, Thomas K, Brenner E, Edmonds E, Calcetas A, Edwards L, et al.
Front Aging Neurosci . 2022 Jul; 14:859873. PMID: 35875798
Intraindividual variability (IIV) across neuropsychological measures within a single testing session is a promising marker predictive of cognitive decline and development of Alzheimer's disease (AD). We have previously shown that...
10.
Brenner E, Grossner E, Johnson B, Bernier R, Soto J, Hillary F
Brain Inj . 2020 Apr; 34(6):799-808. PMID: 32228303
Primary Objective: This study has three goals: to determine whether there is a higher rate of traumatic brain injury (TBI) for people of color (POC), whether TBI studies report racial/ethnic...